Autosomal Dominant Dopa-Responsive Dystonia

Genetic MONDO:0971063 Pathograph 33 Dopa-responsive dystonia Inborn Error of Metabolism Movement Disorder

Autosomal dominant dopa-responsive dystonia is a rare neurometabolic disorder, most commonly caused by heterozygous GCH1 pathogenic variants, in which impaired tetrahydrobiopterin-dependent dopamine synthesis produces childhood onset dystonia with diurnal fluctuation and a dramatic sustained response to low-dose levodopa. Orphanet also lists rarer autosomal dominant disease-causing variants in IMPDH2 and NR4A2.

Ask OpenScientist

Ask a research question about Autosomal Dominant Dopa-Responsive Dystonia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
5
Pathophys.
22
Phenotypes
33
Pathograph
3
Genes
1
Treatments
8
References
1
Deep Research
👪

Inheritance

1
Autosomal dominant inheritance HP:0000006
Classic GTPCH1-deficient dopa-responsive dystonia is inherited in an autosomal dominant manner, with reduced and sex-biased penetrance in GCH1 variant carriers.
Autosomal dominant inheritance
Show evidence (2 references)
PMID:20301681 SUPPORT Other
"GTPCH1-deficient DRD is inherited in an autosomal dominant manner. Affected individuals often have an affected parent with typical GTPCH1-deficient DRD or adult-onset parkinsonism caused by a GCH1 pathogenic variant."
GeneReviews states autosomal dominant inheritance for GTPCH1-deficient DRD.
ORPHA:98808 SUPPORT Other
"Autosomal dominant"
Orphanet records autosomal dominant inheritance.
⚙

Pathophysiology

5
GCH1 Enzymatic Deficiency
Heterozygous pathogenic variants in GCH1 reduce GTP cyclohydrolase I function, the first step of tetrahydrobiopterin synthesis, thereby limiting cofactor availability for dopamine biosynthesis.
GCH1 link
tetrahydrobiopterin biosynthetic process link ↓ DECREASED
GTP cyclohydrolase I activity link ↓ DECREASED
Downstream
BH4-Dependent Catecholamine and Phenylalanine Hydroxylation Impairment Reduced GTP cyclohydrolase I limits BH4 cofactor availability.
Show evidence (3 references)
PMID:8852666 SUPPORT Human Clinical
"Recently the GTP cyclohydrolase I (GTPCH) gene was isolated as the first causative gene for dopa-responsive dystonia (DRD)."
Human family study supports GCH1 as a causative gene for autosomal dominant dopa-responsive dystonia.
PMID:20301681 SUPPORT Other
"The diagnosis of GTPCH1-deficient DRD is established in a proband by identification of a heterozygous pathogenic variant in GCH1 by molecular genetic testing."
GeneReviews summarizes GCH1 heterozygous pathogenic variants as the diagnostic molecular lesion.
ORPHA:98808 SUPPORT Other
"| GCH1 | GTP cyclohydrolase 1 | hgnc:4193 | Disease-causing germline mutation(s) in |"
Orphanet lists GCH1 as a disease-causing gene.
BH4-Dependent Catecholamine and Phenylalanine Hydroxylation Impairment
Reduced tetrahydrobiopterin availability impairs BH4-dependent aromatic amino-acid hydroxylation, lowering catecholamine/dopamine synthesis and explaining the recurrent CSF homovanillic-acid and transient hyperphenylalaninemia readouts recorded for this disorder.
tetrahydrobiopterin biosynthetic process link ↓ DECREASED catecholamine biosynthetic process link ↓ DECREASED L-phenylalanine metabolic process link ↕ DYSREGULATED
Downstream
Striatal Dopamine Biosynthesis Impairment BH4 cofactor limitation reduces dopamine synthesis in motor circuits.
Transient Hyperphenylalaninemia BH4-dependent phenylalanine handling can be transiently abnormal.
Blood phenylalanine Elevated blood phenylalanine reports the hyperphenylalaninemia branch.
Hearing Impairment Orphanet records hearing impairment as frequent in autosomal dominant DRD, but the intermediary mechanism from BH4/GCH1 dysfunction is unresolved in the cached disease-specific sources.
Show evidence (2 references)
PMID:28087438 SUPPORT Human Clinical
"DRD is caused by the mutations in the genes encoding the enzymes involved in the dopamine and tetrahydrobiopterin (BH4) biosynthesis, including the GTP cyclohydrolase 1 (GCH1) gene and the tyrosine hydroxylase (TH) gene."
Human DRD cohort review connects GCH1/BH4 pathway disruption with dopamine and tetrahydrobiopterin biosynthesis.
ORPHA:98808 SUPPORT Other
"| HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |"
Orphanet records transient hyperphenylalaninemia in autosomal dominant dopa-responsive dystonia.
Striatal Dopamine Biosynthesis Impairment
Impaired tetrahydrobiopterin-dependent catecholamine synthesis reduces dopamine production in nigrostriatal circuits, producing dystonia, parkinsonism, rigidity, and tremor that improve when levodopa supplies a downstream dopamine precursor.
dopaminergic neuron link
dopamine biosynthetic process link ↓ DECREASED dopamine biosynthetic process from tyrosine link ↓ DECREASED dopamine receptor signaling pathway link ↓ DECREASED
basal ganglion link
Downstream
Limb Dystonia
Focal Dystonia
Parkinsonism
Rigidity
Extrapyramidal Motor Dysfunction
Postural Tremor
Brisk Reflexes
Lower Limb Hyperreflexia
Babinski Sign
Pes Cavus
Talipes Equinovarus
Torticollis
Ataxia
Gait Ataxia
Decreased CSF Homovanillic Acid
CSF homovanillic acid
Depression
Anxiety
Sleep Abnormality
Fatigue
Show evidence (2 references)
PMID:28087438 SUPPORT Human Clinical
"DRD is caused by the mutations in the genes encoding the enzymes involved in the dopamine and tetrahydrobiopterin (BH4) biosynthesis, including the GTP cyclohydrolase 1 (GCH1) gene and the tyrosine hydroxylase (TH) gene."
Human DRD cohort links GCH1/BH4 pathway disruption to dopamine biosynthesis defects.
PMID:20301681 SUPPORT Other
"GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa."
Levodopa responsiveness supports impaired dopamine synthesis as the proximal reversible neurotransmitter deficit.
IMPDH2-Associated Purine Pathway Deficiency
Rare heterozygous truncating variants in IMPDH2 reduce IMP dehydrogenase function in patient cells, linking impaired guanine nucleotide metabolism to dopamine biosynthesis and autosomal dominant dystonia-tremor phenotypes.
IMPDH2 link
purine nucleotide biosynthetic process link ↓ DECREASED
IMP dehydrogenase activity link ↓ DECREASED
Downstream
Striatal Dopamine Biosynthesis Impairment
Show evidence (3 references)
DOI:10.1038/s41431-021-00939-1 SUPPORT In Vitro
"We show that the defect results in degradation of the gene product, causing IMPDH2 deficiency in patient cells."
Patient-cell evidence supports reduced IMPDH2 protein as the molecular defect.
DOI:10.1038/s41431-021-00939-1 SUPPORT Human Clinical
"Here we report a deleterious heterozygous truncating variant in the inosine monophosphate dehydrogenase gene (IMPDH2) by whole-exome sequencing, co-segregating with a dominantly inherited dystonia-tremor disease in a large Finnish family."
Human segregation evidence supports IMPDH2 as a rarer autosomal dominant dystonia gene.
ORPHA:98808 SUPPORT Other
"| IMPDH2 | inosine monophosphate dehydrogenase 2 | hgnc:6053 | Disease-causing germline mutation(s) (loss of function) in |"
Orphanet lists IMPDH2 loss-of-function variants for this entry.
NR4A2 Haploinsufficiency-Associated Dopaminergic Denervation
Loss-of-function variants in NR4A2 can produce early-adult dystonia parkinsonism with dopaminergic denervation on dopamine-transporter imaging, extending the autosomal dominant dopa-responsive dystonia spectrum.
dopaminergic neuron link
NR4A2 link
substantia nigra link
Downstream
Parkinsonism
Limb Dystonia
Abnormality of the Substantia Nigra
Show evidence (3 references)
PMID:31922365 SUPPORT Human Clinical
"The 2 patients reported here both had a history of mild intellectual disability in childhood and subsequently developed dystonia parkinsonism in early adulthood."
Human cases support NR4A2 loss-of-function variants as a cause of dystonia parkinsonism.
PMID:31922365 SUPPORT Human Clinical
"Brain magnetic resonance imaging was normal, and DATscan suggested bilateral dopaminergic denervation."
Dopamine-transporter imaging supports dopaminergic denervation downstream of NR4A2 haploinsufficiency.
ORPHA:98808 SUPPORT Other
"| NR4A2 | nuclear receptor subfamily 4 group A member 2 | hgnc:7981 | Disease-causing germline mutation(s) (loss of function) in |"
Orphanet lists NR4A2 loss-of-function variants for this entry.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Autosomal Dominant Dopa-Responsive Dystonia Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

22
Ear 1
Hearing Impairment FREQUENT Hearing impairment (HP:0000365)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0000365 | Hearing impairment | Frequent (79-30%) |"
Orphanet lists hearing impairment as frequent.
Limbs 2
Pes Cavus FREQUENT Pes cavus (HP:0001761)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0001761 | Pes cavus | Frequent (79-30%) |"
Orphanet lists pes cavus as frequent.
Talipes Equinovarus FREQUENT Talipes equinovarus (HP:0001762)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0001762 | Talipes equinovarus | Frequent (79-30%) |"
Orphanet lists talipes equinovarus as frequent.
Musculoskeletal 1
Rigidity FREQUENT Rigidity (HP:0002063)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0002063 | Rigidity | Frequent (79-30%) |"
Orphanet lists rigidity as frequent.
Nervous System 6
Parkinsonism FREQUENT Parkinsonism (HP:0001300)
Show evidence (2 references)
ORPHA:98808 SUPPORT Other
"| HP:0001300 | Parkinsonism | Frequent (79-30%) |"
Orphanet lists parkinsonism as frequent.
PMID:20301681 SUPPORT Other
"This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep)."
GeneReviews supports later parkinsonism as part of the syndrome.
Ataxia FREQUENT Ataxia (HP:0001251)
Show evidence (2 references)
ORPHA:98808 SUPPORT Other
"| HP:0001251 | Ataxia | Frequent (79-30%) |"
Orphanet lists ataxia as frequent.
PMID:20301681 REFUTE Other
"Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur."
GeneReviews raises a discrepancy with the Orphanet ataxia annotation by stating that cerebellar disturbances generally do not occur.
Gait Ataxia FREQUENT Gait ataxia (HP:0002066)
Show evidence (2 references)
ORPHA:98808 SUPPORT Other
"| HP:0002066 | Gait ataxia | Frequent (79-30%) |"
Orphanet lists gait ataxia as frequent.
PMID:20301681 REFUTE Other
"Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur."
GeneReviews raises a discrepancy with the Orphanet gait ataxia annotation by stating that cerebellar disturbances generally do not occur.
Depression FREQUENT Depression (HP:0000716)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0000716 | Depression | Frequent (79-30%) |"
Orphanet lists depression as frequent.
Anxiety FREQUENT Anxiety (HP:0000739)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0000739 | Anxiety | Frequent (79-30%) |"
Orphanet lists anxiety as frequent.
Sleep Abnormality FREQUENT Sleep disturbance (HP:0002360)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0002360 | Sleep abnormality | Frequent (79-30%) |"
Orphanet lists sleep abnormality as frequent.
Constitutional 1
Fatigue FREQUENT Fatigue (HP:0012378)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0012378 | Fatigue | Frequent (79-30%) |"
Orphanet lists fatigue as frequent.
Other 11
Limb Dystonia FREQUENT Limb dystonia (HP:0002451)
Temporal: DIURNAL
Show evidence (3 references)
ORPHA:98808 SUPPORT Other
"| HP:0002451 | Limb dystonia | Frequent (79-30%) |"
Orphanet lists limb dystonia as frequent.
PMID:20301681 SUPPORT Other
"This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep)."
GeneReviews describes foot dystonia as a typical presenting feature.
PMID:33875303 SUPPORT Human Clinical
"gait disturbance was reported in 92.7% of patients, diurnal fluctuation of symptoms in 91.9%, and RMS in 39%."
Human case-series/meta-analysis evidence supports diurnal fluctuation as a common temporal pattern of early-onset autosomal dominant GCH1 deficiency.
Focal Dystonia FREQUENT Focal dystonia (HP:0004373)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0004373 | Focal dystonia | Frequent (79-30%) |"
Orphanet lists focal dystonia as frequent.
Extrapyramidal Motor Dysfunction FREQUENT Abnormality of extrapyramidal motor function (HP:0002071)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0002071 | Abnormality of extrapyramidal motor function | Frequent (79-30%) |"
Orphanet lists abnormal extrapyramidal motor function as frequent.
Postural Tremor FREQUENT Postural tremor (HP:0002174)
Show evidence (2 references)
ORPHA:98808 SUPPORT Other
"| HP:0002174 | Postural tremor | Frequent (79-30%) |"
Orphanet lists postural tremor as frequent.
PMID:20301681 SUPPORT Other
"Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements."
GeneReviews supports postural tremor as a presenting symptom.
Brisk Reflexes FREQUENT Brisk reflexes (HP:0001348)
Show evidence (2 references)
ORPHA:98808 SUPPORT Other
"| HP:0001348 | Brisk reflexes | Frequent (79-30%) |"
Orphanet lists brisk reflexes as frequent.
PMID:20301681 SUPPORT Other
"Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals."
GeneReviews supports brisk lower-limb reflexes in many patients.
Lower Limb Hyperreflexia FREQUENT Lower limb hyperreflexia (HP:0002395)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0002395 | Lower limb hyperreflexia | Frequent (79-30%) |"
Orphanet lists lower limb hyperreflexia as frequent.
Babinski Sign FREQUENT Babinski sign (HP:0003487)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0003487 | Babinski sign | Frequent (79-30%) |"
Orphanet lists Babinski sign as frequent.
Decreased CSF Homovanillic Acid FREQUENT Decreased CSF homovanillic acid concentration (HP:0003785)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0003785 | Decreased CSF homovanillic acid concentration | Frequent (79-30%) |"
Orphanet lists decreased CSF homovanillic acid concentration as frequent.
Abnormality of the Substantia Nigra FREQUENT Abnormal substantia nigra morphology (HP:0045007)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0045007 | Abnormality of the substantia nigra | Frequent (79-30%) |"
Orphanet lists substantia nigra abnormality as frequent.
Torticollis FREQUENT Torticollis (HP:0000473)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0000473 | Torticollis | Frequent (79-30%) |"
Orphanet lists torticollis as frequent.
Transient Hyperphenylalaninemia FREQUENT Transient hyperphenylalaninemia (HP:0008297)
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |"
Orphanet lists transient hyperphenylalaninemia as frequent.
🧬

Genetic Associations

3
GCH1 heterozygous pathogenic variants (Autosomal dominant pathogenic variants)
Autosomal dominant
Show evidence (1 reference)
PMID:20301681 SUPPORT Other
"The diagnosis of GTPCH1-deficient DRD is established in a proband by identification of a heterozygous pathogenic variant in GCH1 by molecular genetic testing."
Supports GCH1 heterozygous pathogenic variants as diagnostic.
IMPDH2 loss-of-function variants (Loss-of-function variants)
Show evidence (2 references)
DOI:10.1038/s41431-021-00939-1 SUPPORT Human Clinical
"Here we report a deleterious heterozygous truncating variant in the inosine monophosphate dehydrogenase gene (IMPDH2) by whole-exome sequencing, co-segregating with a dominantly inherited dystonia-tremor disease in a large Finnish family."
Supports IMPDH2 as a rarer autosomal dominant dystonia gene.
ORPHA:98808 SUPPORT Other
"| IMPDH2 | inosine monophosphate dehydrogenase 2 | hgnc:6053 | Disease-causing germline mutation(s) (loss of function) in |"
Orphanet lists IMPDH2 for this disease entry.
NR4A2 loss-of-function variants (Loss-of-function variants)
Show evidence (2 references)
PMID:31922365 SUPPORT Human Clinical
"Two frameshift mutations in NR4A2 were identified: a de novo insertion (NM_006186.3; c.326dupA) in the first case and another small insertion (NM_006186.3; c.881dupA) in the second."
Supports NR4A2 loss-of-function variants in human cases.
ORPHA:98808 SUPPORT Other
"| NR4A2 | nuclear receptor subfamily 4 group A member 2 | hgnc:7981 | Disease-causing germline mutation(s) (loss of function) in |"
Orphanet lists NR4A2 for this disease entry.
💊

Treatments

1
Low-dose levodopa therapy
Action: Pharmacotherapy NCIT:C15986
Agent: levodopa ↗
Low-dose levodopa, typically with a decarboxylase inhibitor, bypasses the upstream dopamine-synthesis bottleneck and produces rapid, sustained motor improvement. Discontinuation of levodopa treatment should be avoided.
Mechanism Target:
BYPASSES Striatal Dopamine Biosynthesis Impairment
Target Phenotypes: Limb dystonia ↗ Parkinsonism ↗
Show evidence (3 references)
PMID:20301681 SUPPORT Other
"Motor benefit occurs immediately or within a few days of starting levodopa; full benefit occurs within several days to a few months. Maximum benefit (complete or near-complete responsiveness of symptoms) is generally achieved by <300-400 mg/day of levodopa/DCI."
GeneReviews supports low-dose levodopa as the core symptomatic therapy.
PMID:20301681 SUPPORT Other
"Agents/circumstances to avoid: Discontinuation of levodopa treatment."
GeneReviews states that discontinuing levodopa should be avoided.
ORPHA:98808 SUPPORT Other
"A rare neurometabolic disorder characterized by childhood-onset dystonia that shows a dramatic and sustained response to low doses of levodopa (L-dopa) and that may be associated with parkinsonism at an older age."
Orphanet definition supports dramatic sustained levodopa response.
🔬

Biochemical Markers

2
CSF homovanillic acid (DECREASED)
Context: Low CSF homovanillic acid is a central dopamine-metabolite clue that reports impaired dopamine biosynthesis in GTPCH1-deficient dopa-responsive dystonia.
Pathograph Readouts
Readout Of Striatal Dopamine Biosynthesis Impairment Negative Diagnostic
Low CSF HVA reports reduced central dopamine synthesis.
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0003785 | Decreased CSF homovanillic acid concentration | Frequent (79-30%) |"
Orphanet lists decreased CSF homovanillic acid as frequent.
Blood phenylalanine (INCREASED)
Context: Transient hyperphenylalaninemia is a metabolic readout of the BH4-dependent aromatic amino-acid hydroxylation branch in this Orphanet disease record.
Pathograph Readouts
Readout Of BH4-Dependent Catecholamine and Phenylalanine Hydroxylation Impairment Positive Diagnostic
Elevated blood phenylalanine reports impaired BH4-dependent phenylalanine handling.
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"| HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |"
Orphanet lists transient hyperphenylalaninemia as frequent.
{ }

Source YAML

click to show 
name: Autosomal Dominant Dopa-Responsive Dystonia
creation_date: "2026-05-06T05:35:00Z"
updated_date: "2026-05-19T14:18:33Z"
category: Genetic
parents:
- Dopa-responsive dystonia
- Inborn Error of Metabolism
- Movement Disorder
disease_term:
  preferred_term: autosomal dominant dopa-responsive dystonia
  term:
    id: MONDO:0971063
    label: autosomal dominant dopa-responsive dystonia
description: >-
  Autosomal dominant dopa-responsive dystonia is a rare neurometabolic disorder,
  most commonly caused by heterozygous GCH1 pathogenic variants, in which
  impaired tetrahydrobiopterin-dependent dopamine synthesis produces childhood
  onset dystonia with diurnal fluctuation and a dramatic sustained response to
  low-dose levodopa. Orphanet also lists rarer autosomal dominant disease-causing
  variants in IMPDH2 and NR4A2.
references:
- reference: ORPHA:98808
  title: Autosomal dominant dopa-responsive dystonia
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: >-
      Orphanet defines autosomal dominant dopa-responsive dystonia as a rare
      neurometabolic disorder with childhood-onset dystonia and sustained
      low-dose levodopa response.
    supporting_text: >-
      A rare neurometabolic disorder characterized by childhood-onset dystonia
      that shows a dramatic and sustained response to low doses of levodopa
      (L-dopa) and that may be associated with parkinsonism at an older age.
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A rare neurometabolic disorder characterized by childhood-onset dystonia
        that shows a dramatic and sustained response to low doses of levodopa
        (L-dopa) and that may be associated with parkinsonism at an older age.
      explanation: >-
        Orphanet definition supports the disease scope and core clinical
        response pattern.
- reference: PMID:20301681
  title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
  tags:
  - GeneReviews
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: >-
      GeneReviews supports GCH1 molecular diagnosis, autosomal dominant
      inheritance, core clinical characteristics, and levodopa management.
    supporting_text: >-
      GTPCH1-deficient DRD is characterized by childhood-onset dystonia,
      diurnal fluctuation, dramatic sustained response to low-dose levodopa,
      and diagnosis by heterozygous GCH1 pathogenic variant.
- reference: PMID:8852666
  title: "Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity."
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: Human family evidence identifies GCH1/GTPCH as a causative gene for dopa-responsive dystonia.
    supporting_text: >-
      The study analyzed British families and sporadic cases after GTPCH was
      identified as the first causative gene for dopa-responsive dystonia.
- reference: PMID:28087438
  title: "Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis."
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: DRD genes affect dopamine and tetrahydrobiopterin biosynthesis.
    supporting_text: >-
      The cohort review states that DRD is caused by mutations in genes encoding
      enzymes involved in dopamine and tetrahydrobiopterin biosynthesis.
- reference: PMID:33875303
  title: "Early-onset autosomal dominant GTP-cyclohydrolase I deficiency: Diagnostic delay and residual motor signs."
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: Early-onset AD GCH1 deficiency commonly has gait disturbance and diurnal fluctuation, and delayed diagnosis is associated with residual motor signs.
    supporting_text: >-
      Case-series and meta-analysis data reported gait disturbance in 92.7%,
      diurnal fluctuation in 91.9%, and an association between diagnostic delay
      and residual motor signs.
- reference: PMID:31922365
  title: Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: NR4A2 loss-of-function variants can cause dystonia parkinsonism with dopaminergic denervation.
    supporting_text: >-
      Two patients had NR4A2 frameshift variants, dystonia parkinsonism, and
      DATscan evidence suggesting bilateral dopaminergic denervation.
- reference: DOI:10.1038/s41431-021-00939-1
  title: "IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder"
  found_in:
  - Autosomal_Dominant_Dopa_Responsive_Dystonia-deep-research-fallback.md
  findings:
  - statement: IMPDH2 truncating variants cause a dominantly inherited dystonia-tremor disorder with patient-cell IMPDH2 deficiency.
    supporting_text: >-
      The study reports a heterozygous truncating IMPDH2 variant cosegregating
      with dominantly inherited dystonia-tremor disease and degradation of the
      gene product in patient cells.
- reference: DOI:10.1002/mdc3.14157
  title: "Autosomal Recessive Guanosine Triphosphate Cyclohydrolase I Deficiency: Redefining the Phenotypic Spectrum and Outcomes"
  findings:
  - statement: >-
      GCH1 encodes GTP cyclohydrolase I, the rate-limiting enzyme in
      tetrahydrobiopterin biosynthesis and a cofactor source for monoamine
      neurotransmitter production.
    supporting_text: >-
      The GCH1 gene encodes the enzyme guanosine triphosphate cyclohydrolase I
      (GTPCH), which catalyzes the rate‐limiting step in the biosynthesis of
      tetrahydrobiopterin (BH4), a critical cofactor in the production of
      monoamine neurotransmitters.
inheritance:
- name: Autosomal dominant inheritance
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    Classic GTPCH1-deficient dopa-responsive dystonia is inherited in an
    autosomal dominant manner, with reduced and sex-biased penetrance in GCH1
    variant carriers.
  evidence:
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      GTPCH1-deficient DRD is inherited in an autosomal dominant manner.
      Affected individuals often have an affected parent with typical
      GTPCH1-deficient DRD or adult-onset parkinsonism caused by a GCH1
      pathogenic variant.
    explanation: GeneReviews states autosomal dominant inheritance for GTPCH1-deficient DRD.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Autosomal dominant
    explanation: Orphanet records autosomal dominant inheritance.
pathophysiology:
- name: GCH1 Enzymatic Deficiency
  description: >-
    Heterozygous pathogenic variants in GCH1 reduce GTP cyclohydrolase I
    function, the first step of tetrahydrobiopterin synthesis, thereby limiting
    cofactor availability for dopamine biosynthesis.
  genes:
  - preferred_term: GCH1
    term:
      id: hgnc:4193
      label: GCH1
  molecular_functions:
  - preferred_term: GTP cyclohydrolase I activity
    term:
      id: GO:0003934
      label: GTP cyclohydrolase I activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: tetrahydrobiopterin biosynthetic process
    term:
      id: GO:0006729
      label: tetrahydrobiopterin biosynthetic process
    modifier: DECREASED
  chemical_entities:
  - preferred_term: tetrahydrobiopterin
    term:
      id: CHEBI:15372
      label: 5,6,7,8-tetrahydrobiopterin
    modifier: DECREASED
  downstream:
  - target: BH4-Dependent Catecholamine and Phenylalanine Hydroxylation Impairment
    description: Reduced GTP cyclohydrolase I limits BH4 cofactor availability.
    causal_link_type: DIRECT
    evidence:
    - reference: DOI:10.1002/mdc3.14157
      reference_title: 'Autosomal Recessive Guanosine Triphosphate Cyclohydrolase I Deficiency: Redefining the Phenotypic Spectrum and Outcomes'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The GCH1 gene encodes the enzyme guanosine triphosphate cyclohydrolase
        I (GTPCH), which catalyzes the rate‐limiting step in the biosynthesis
        of tetrahydrobiopterin (BH4), a critical cofactor in the production of
        monoamine neurotransmitters.
      explanation: >-
        Human GCH1 deficiency review directly links GCH1/GTPCH to BH4
        biosynthesis and monoamine neurotransmitter production.
  evidence:
  - reference: PMID:8852666
    reference_title: 'Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recently the GTP cyclohydrolase I (GTPCH) gene was isolated as the first
      causative gene for dopa-responsive dystonia (DRD).
    explanation: >-
      Human family study supports GCH1 as a causative gene for autosomal
      dominant dopa-responsive dystonia.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of GTPCH1-deficient DRD is established in a proband by
      identification of a heterozygous pathogenic variant in GCH1 by molecular
      genetic testing.
    explanation: >-
      GeneReviews summarizes GCH1 heterozygous pathogenic variants as the
      diagnostic molecular lesion.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | GCH1 | GTP cyclohydrolase 1 | hgnc:4193 | Disease-causing germline
      mutation(s) in |
    explanation: Orphanet lists GCH1 as a disease-causing gene.
- name: BH4-Dependent Catecholamine and Phenylalanine Hydroxylation Impairment
  description: >-
    Reduced tetrahydrobiopterin availability impairs BH4-dependent aromatic
    amino-acid hydroxylation, lowering catecholamine/dopamine synthesis and
    explaining the recurrent CSF homovanillic-acid and transient
    hyperphenylalaninemia readouts recorded for this disorder.
  biological_processes:
  - preferred_term: tetrahydrobiopterin biosynthetic process
    term:
      id: GO:0006729
      label: tetrahydrobiopterin biosynthetic process
    modifier: DECREASED
  - preferred_term: catecholamine biosynthetic process
    term:
      id: GO:0042423
      label: catecholamine biosynthetic process
    modifier: DECREASED
  - preferred_term: L-phenylalanine metabolic process
    term:
      id: GO:0006558
      label: L-phenylalanine metabolic process
    modifier: DYSREGULATED
  chemical_entities:
  - preferred_term: tetrahydrobiopterin
    term:
      id: CHEBI:15372
      label: 5,6,7,8-tetrahydrobiopterin
    modifier: DECREASED
  - preferred_term: dopamine
    term:
      id: CHEBI:18243
      label: dopamine
    modifier: DECREASED
  - preferred_term: L-phenylalanine
    term:
      id: CHEBI:58095
      label: L-phenylalanine zwitterion
    modifier: INCREASED
  evidence:
  - reference: PMID:28087438
    reference_title: 'Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      DRD is caused by the mutations in the genes encoding the enzymes involved
      in the dopamine and tetrahydrobiopterin (BH4) biosynthesis, including the
      GTP cyclohydrolase 1 (GCH1) gene and the tyrosine hydroxylase (TH) gene.
    explanation: >-
      Human DRD cohort review connects GCH1/BH4 pathway disruption with
      dopamine and tetrahydrobiopterin biosynthesis.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |
    explanation: >-
      Orphanet records transient hyperphenylalaninemia in autosomal dominant
      dopa-responsive dystonia.
  downstream:
  - target: Striatal Dopamine Biosynthesis Impairment
    description: BH4 cofactor limitation reduces dopamine synthesis in motor circuits.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:28087438
      reference_title: 'Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        DRD is caused by the mutations in the genes encoding the enzymes
        involved in the dopamine and tetrahydrobiopterin (BH4) biosynthesis,
        including the GTP cyclohydrolase 1 (GCH1) gene and the tyrosine
        hydroxylase (TH) gene.
      explanation: >-
        Human DRD cohort review links BH4/GCH1 disruption to impaired dopamine
        biosynthesis.
  - target: Transient Hyperphenylalaninemia
    description: BH4-dependent phenylalanine handling can be transiently abnormal.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - reduced BH4 cofactor availability for aromatic amino-acid hydroxylases
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        | HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |
      explanation: >-
        Orphanet lists transient hyperphenylalaninemia as a frequent phenotype
        in this AD DRD record.
  - target: Blood phenylalanine
    description: Elevated blood phenylalanine reports the hyperphenylalaninemia branch.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - reduced BH4 cofactor availability for aromatic amino-acid hydroxylases
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        | HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |
      explanation: >-
        Orphanet phenotype annotation supports elevated phenylalanine as a
        disease-associated biochemical readout.
  - target: Hearing Impairment
    description: >-
      Orphanet records hearing impairment as frequent in autosomal dominant DRD,
      but the intermediary mechanism from BH4/GCH1 dysfunction is unresolved in
      the cached disease-specific sources.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0000365 | Hearing impairment | Frequent (79-30%) |"
      explanation: >-
        Orphanet lists hearing impairment as a frequent phenotype; this edge is
        intentionally marked with unknown intermediates.
- name: Striatal Dopamine Biosynthesis Impairment
  description: >-
    Impaired tetrahydrobiopterin-dependent catecholamine synthesis reduces
    dopamine production in nigrostriatal circuits, producing dystonia,
    parkinsonism, rigidity, and tremor that improve when levodopa supplies a
    downstream dopamine precursor.
  cell_types:
  - preferred_term: dopaminergic neuron
    term:
      id: CL:0000700
      label: dopaminergic neuron
  locations:
  - preferred_term: basal ganglion
    term:
      id: UBERON:0002420
      label: basal ganglion
  biological_processes:
  - preferred_term: dopamine biosynthetic process
    term:
      id: GO:0042416
      label: dopamine biosynthetic process
    modifier: DECREASED
  - preferred_term: dopamine biosynthetic process from tyrosine
    term:
      id: GO:0006585
      label: dopamine biosynthetic process from tyrosine
    modifier: DECREASED
  - preferred_term: dopamine receptor signaling pathway
    term:
      id: GO:0007212
      label: G protein-coupled dopamine receptor signaling pathway
    modifier: DECREASED
  chemical_entities:
  - preferred_term: dopamine
    term:
      id: CHEBI:18243
      label: dopamine
    modifier: DECREASED
  - preferred_term: homovanillic acid
    term:
      id: CHEBI:545959
      label: homovanillic acid
    modifier: DECREASED
  downstream:
  - target: Limb Dystonia
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        This disorder typically presents with gait disturbance caused by foot
        dystonia, later development of parkinsonism, and diurnal fluctuation of
        symptoms (aggravation of symptoms toward the evening and alleviation of
        symptoms in the morning after sleep).
      explanation: GeneReviews links the core disorder to foot/limb dystonia.
  - target: Focal Dystonia
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Occasionally, initial symptoms are arm dystonia, postural tremor of the
        hand, or slowness of movements.
      explanation: GeneReviews describes focal arm dystonia as an initial motor sign.
  - target: Parkinsonism
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        This disorder typically presents with gait disturbance caused by foot
        dystonia, later development of parkinsonism, and diurnal fluctuation of
        symptoms (aggravation of symptoms toward the evening and alleviation of
        symptoms in the morning after sleep).
      explanation: GeneReviews links later parkinsonism to GTPCH1-deficient DRD.
  - target: Rigidity
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0002063 | Rigidity | Frequent (79-30%) |"
      explanation: Orphanet lists rigidity as a frequent AD DRD phenotype.
  - target: Extrapyramidal Motor Dysfunction
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        | HP:0002071 | Abnormality of extrapyramidal motor function | Frequent
        (79-30%) |
      explanation: Orphanet lists extrapyramidal motor dysfunction as frequent.
  - target: Postural Tremor
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Occasionally, initial symptoms are arm dystonia, postural tremor of the
        hand, or slowness of movements.
      explanation: GeneReviews includes postural tremor among initial symptoms.
  - target: Brisk Reflexes
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the
        striatal toe (dystonic extension of the big toe) are present in many
        affected individuals.
      explanation: GeneReviews supports brisk reflexes in many affected individuals.
  - target: Lower Limb Hyperreflexia
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the
        striatal toe (dystonic extension of the big toe) are present in many
        affected individuals.
      explanation: GeneReviews supports lower-limb hyperreflexia.
  - target: Babinski Sign
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the
        striatal toe (dystonic extension of the big toe) are present in many
        affected individuals.
      explanation: GeneReviews supports striatal toe/Babinski-like pyramidal sign.
  - target: Pes Cavus
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - chronic foot dystonia and abnormal lower-limb posture
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0001761 | Pes cavus | Frequent (79-30%) |"
      explanation: Orphanet lists pes cavus as a frequent foot phenotype.
  - target: Talipes Equinovarus
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - chronic foot dystonia and flexion-inversion posture
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Initial symptoms are often gait difficulties attributable to
        flexion-inversion (equinovarus posture) of the foot.
      explanation: GeneReviews directly describes equinovarus foot posture.
  - target: Torticollis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0000473 | Torticollis | Frequent (79-30%) |"
      explanation: Orphanet lists torticollis as frequent in AD DRD.
  - target: Ataxia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0001251 | Ataxia | Frequent (79-30%) |"
      explanation: Orphanet lists ataxia as frequent; the precise intermediate is unresolved.
  - target: Gait Ataxia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0002066 | Gait ataxia | Frequent (79-30%) |"
      explanation: Orphanet lists gait ataxia as frequent; the precise intermediate is unresolved.
  - target: Decreased CSF Homovanillic Acid
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        | HP:0003785 | Decreased CSF homovanillic acid concentration | Frequent
        (79-30%) |
      explanation: >-
        Orphanet lists low CSF homovanillic acid, a dopamine metabolite readout,
        as frequent.
  - target: CSF homovanillic acid
    causal_link_type: DIRECT
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        | HP:0003785 | Decreased CSF homovanillic acid concentration | Frequent
        (79-30%) |
      explanation: Orphanet supports the decreased CSF HVA biochemical readout.
  - target: Depression
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0000716 | Depression | Frequent (79-30%) |"
      explanation: Orphanet lists depression as frequent in AD DRD.
  - target: Anxiety
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0000739 | Anxiety | Frequent (79-30%) |"
      explanation: Orphanet lists anxiety as frequent in AD DRD.
  - target: Sleep Abnormality
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0002360 | Sleep abnormality | Frequent (79-30%) |"
      explanation: Orphanet lists sleep abnormality as frequent in AD DRD.
  - target: Fatigue
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: ORPHA:98808
      reference_title: Autosomal dominant dopa-responsive dystonia
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "| HP:0012378 | Fatigue | Frequent (79-30%) |"
      explanation: Orphanet lists fatigue as frequent in AD DRD.
  evidence:
  - reference: PMID:28087438
    reference_title: 'Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      DRD is caused by the mutations in the genes encoding the enzymes involved
      in the dopamine and tetrahydrobiopterin (BH4) biosynthesis, including the
      GTP cyclohydrolase 1 (GCH1) gene and the tyrosine hydroxylase (TH) gene.
    explanation: >-
      Human DRD cohort links GCH1/BH4 pathway disruption to dopamine
      biosynthesis defects.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient
      DRD) is characterized by childhood-onset dystonia and a dramatic and
      sustained response to low doses of oral administration of levodopa.
    explanation: >-
      Levodopa responsiveness supports impaired dopamine synthesis as the
      proximal reversible neurotransmitter deficit.
- name: IMPDH2-Associated Purine Pathway Deficiency
  description: >-
    Rare heterozygous truncating variants in IMPDH2 reduce IMP dehydrogenase
    function in patient cells, linking impaired guanine nucleotide metabolism to
    dopamine biosynthesis and autosomal dominant dystonia-tremor phenotypes.
  genes:
  - preferred_term: IMPDH2
    term:
      id: hgnc:6053
      label: IMPDH2
  molecular_functions:
  - preferred_term: IMP dehydrogenase activity
    term:
      id: GO:0003938
      label: IMP dehydrogenase activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: purine nucleotide biosynthetic process
    term:
      id: GO:0006164
      label: purine nucleotide biosynthetic process
    modifier: DECREASED
  downstream:
  - target: Striatal Dopamine Biosynthesis Impairment
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  evidence:
  - reference: DOI:10.1038/s41431-021-00939-1
    reference_title: 'IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder'
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We show that the defect results in degradation of the gene product,
      causing IMPDH2 deficiency in patient cells.
    explanation: >-
      Patient-cell evidence supports reduced IMPDH2 protein as the molecular
      defect.
  - reference: DOI:10.1038/s41431-021-00939-1
    reference_title: 'IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here we report a deleterious heterozygous truncating variant in the
      inosine monophosphate dehydrogenase gene (IMPDH2) by whole-exome
      sequencing, co-segregating with a dominantly inherited dystonia-tremor
      disease in a large Finnish family.
    explanation: >-
      Human segregation evidence supports IMPDH2 as a rarer autosomal dominant
      dystonia gene.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | IMPDH2 | inosine monophosphate dehydrogenase 2 | hgnc:6053 |
      Disease-causing germline mutation(s) (loss of function) in |
    explanation: Orphanet lists IMPDH2 loss-of-function variants for this entry.
- name: NR4A2 Haploinsufficiency-Associated Dopaminergic Denervation
  description: >-
    Loss-of-function variants in NR4A2 can produce early-adult dystonia
    parkinsonism with dopaminergic denervation on dopamine-transporter imaging,
    extending the autosomal dominant dopa-responsive dystonia spectrum.
  genes:
  - preferred_term: NR4A2
    term:
      id: hgnc:7981
      label: NR4A2
  cell_types:
  - preferred_term: dopaminergic neuron
    term:
      id: CL:0000700
      label: dopaminergic neuron
  locations:
  - preferred_term: substantia nigra
    term:
      id: UBERON:0002038
      label: substantia nigra
  downstream:
  - target: Parkinsonism
    causal_link_type: DIRECT
  - target: Limb Dystonia
    causal_link_type: DIRECT
  - target: Abnormality of the Substantia Nigra
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - dopamine-transporter imaging abnormality
    evidence:
    - reference: PMID:31922365
      reference_title: Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Brain magnetic resonance imaging was normal, and DATscan suggested
        bilateral dopaminergic denervation.
      explanation: >-
        DATscan evidence supports dopaminergic denervation as a substrate for
        substantia nigra/dopaminergic pathway involvement.
  evidence:
  - reference: PMID:31922365
    reference_title: Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The 2 patients reported here both had a history of mild intellectual
      disability in childhood and subsequently developed dystonia parkinsonism in
      early adulthood.
    explanation: >-
      Human cases support NR4A2 loss-of-function variants as a cause of dystonia
      parkinsonism.
  - reference: PMID:31922365
    reference_title: Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Brain magnetic resonance imaging was normal, and DATscan suggested
      bilateral dopaminergic denervation.
    explanation: >-
      Dopamine-transporter imaging supports dopaminergic denervation downstream
      of NR4A2 haploinsufficiency.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | NR4A2 | nuclear receptor subfamily 4 group A member 2 | hgnc:7981 |
      Disease-causing germline mutation(s) (loss of function) in |
    explanation: Orphanet lists NR4A2 loss-of-function variants for this entry.
phenotypes:
- category: Neurologic
  name: Limb Dystonia
  description: >-
    Limb dystonia is a frequent manifestation and often presents as childhood
    gait disturbance caused by foot dystonia.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Limb dystonia
    term:
      id: HP:0002451
      label: Limb dystonia
    temporality: DIURNAL
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0002451 | Limb dystonia | Frequent (79-30%) |"
    explanation: Orphanet lists limb dystonia as frequent.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This disorder typically presents with gait disturbance caused by foot
      dystonia, later development of parkinsonism, and diurnal fluctuation of
      symptoms (aggravation of symptoms toward the evening and alleviation of
      symptoms in the morning after sleep).
    explanation: >-
      GeneReviews describes foot dystonia as a typical presenting feature.
  - reference: PMID:33875303
    reference_title: 'Early-onset autosomal dominant GTP-cyclohydrolase I deficiency: Diagnostic delay and residual motor signs.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      gait disturbance was reported in 92.7% of patients, diurnal fluctuation of
      symptoms in 91.9%, and RMS in 39%.
    explanation: >-
      Human case-series/meta-analysis evidence supports diurnal fluctuation as a
      common temporal pattern of early-onset autosomal dominant GCH1 deficiency.
- category: Neurologic
  name: Focal Dystonia
  description: Focal dystonia is reported frequently in Orphanet.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Focal dystonia
    term:
      id: HP:0004373
      label: Focal dystonia
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0004373 | Focal dystonia | Frequent (79-30%) |"
    explanation: Orphanet lists focal dystonia as frequent.
- category: Neurologic
  name: Parkinsonism
  description: Parkinsonism may develop later, especially in older patients.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Parkinsonism
    term:
      id: HP:0001300
      label: Parkinsonism
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0001300 | Parkinsonism | Frequent (79-30%) |"
    explanation: Orphanet lists parkinsonism as frequent.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This disorder typically presents with gait disturbance caused by foot
      dystonia, later development of parkinsonism, and diurnal fluctuation of
      symptoms (aggravation of symptoms toward the evening and alleviation of
      symptoms in the morning after sleep).
    explanation: GeneReviews supports later parkinsonism as part of the syndrome.
- category: Neurologic
  name: Rigidity
  description: Rigidity is a frequent extrapyramidal motor feature.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Rigidity
    term:
      id: HP:0002063
      label: Rigidity
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0002063 | Rigidity | Frequent (79-30%) |"
    explanation: Orphanet lists rigidity as frequent.
- category: Neurologic
  name: Extrapyramidal Motor Dysfunction
  description: Extrapyramidal motor dysfunction is frequent in this disorder.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abnormality of extrapyramidal motor function
    term:
      id: HP:0002071
      label: Abnormality of extrapyramidal motor function
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0002071 | Abnormality of extrapyramidal motor function | Frequent
      (79-30%) |
    explanation: >-
      Orphanet lists abnormal extrapyramidal motor function as frequent.
- category: Neurologic
  name: Postural Tremor
  description: Postural tremor can occur as an initial or associated motor sign.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Postural tremor
    term:
      id: HP:0002174
      label: Postural tremor
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0002174 | Postural tremor | Frequent (79-30%) |"
    explanation: Orphanet lists postural tremor as frequent.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Occasionally, initial symptoms are arm dystonia, postural tremor of the
      hand, or slowness of movements.
    explanation: GeneReviews supports postural tremor as a presenting symptom.
- category: Neurologic
  name: Brisk Reflexes
  description: Brisk reflexes are frequent, especially in the lower limbs.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Brisk reflexes
    term:
      id: HP:0001348
      label: Brisk reflexes
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0001348 | Brisk reflexes | Frequent (79-30%) |"
    explanation: Orphanet lists brisk reflexes as frequent.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal
      toe (dystonic extension of the big toe) are present in many affected
      individuals.
    explanation: GeneReviews supports brisk lower-limb reflexes in many patients.
- category: Neurologic
  name: Lower Limb Hyperreflexia
  description: Lower limb hyperreflexia is frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Lower limb hyperreflexia
    term:
      id: HP:0002395
      label: Lower limb hyperreflexia
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0002395 | Lower limb hyperreflexia | Frequent (79-30%) |"
    explanation: Orphanet lists lower limb hyperreflexia as frequent.
- category: Neurologic
  name: Babinski Sign
  description: Babinski sign is frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Babinski sign
    term:
      id: HP:0003487
      label: Babinski sign
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0003487 | Babinski sign | Frequent (79-30%) |"
    explanation: Orphanet lists Babinski sign as frequent.
- category: Neurologic
  name: Ataxia
  description: >-
    Ataxia is reported as frequent by Orphanet, but GeneReviews states that
    cerebellar disturbances generally do not occur in GTPCH1-deficient DRD;
    this discrepancy is preserved for future review.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Ataxia
    term:
      id: HP:0001251
      label: Ataxia
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0001251 | Ataxia | Frequent (79-30%) |"
    explanation: Orphanet lists ataxia as frequent.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      Intellectual, cerebellar, sensory, and autonomic disturbances generally
      do not occur.
    explanation: >-
      GeneReviews raises a discrepancy with the Orphanet ataxia annotation by
      stating that cerebellar disturbances generally do not occur.
- category: Neurologic
  name: Gait Ataxia
  description: >-
    Gait ataxia is reported as frequent by Orphanet, but GeneReviews indicates
    that cerebellar disturbance is generally absent; this may reflect dystonic
    gait being recorded under an ataxia label.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Gait ataxia
    term:
      id: HP:0002066
      label: Gait ataxia
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0002066 | Gait ataxia | Frequent (79-30%) |"
    explanation: Orphanet lists gait ataxia as frequent.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      Intellectual, cerebellar, sensory, and autonomic disturbances generally
      do not occur.
    explanation: >-
      GeneReviews raises a discrepancy with the Orphanet gait ataxia annotation
      by stating that cerebellar disturbances generally do not occur.
- category: Neurologic
  name: Decreased CSF Homovanillic Acid
  description: >-
    Decreased CSF homovanillic acid reflects impaired central dopamine
    metabolism and is listed by Orphanet as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Decreased CSF homovanillic acid concentration
    term:
      id: HP:0003785
      label: Decreased CSF homovanillic acid concentration
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0003785 | Decreased CSF homovanillic acid concentration | Frequent
      (79-30%) |
    explanation: >-
      Orphanet lists decreased CSF homovanillic acid concentration as frequent.
- category: Neurologic
  name: Abnormality of the Substantia Nigra
  description: Substantia nigra abnormalities are listed by Orphanet as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abnormality of the substantia nigra
    term:
      id: HP:0045007
      label: Abnormal substantia nigra morphology
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0045007 | Abnormality of the substantia nigra | Frequent (79-30%) |
    explanation: Orphanet lists substantia nigra abnormality as frequent.
- category: Musculoskeletal
  name: Pes Cavus
  description: Pes cavus is a frequent foot phenotype.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Pes cavus
    term:
      id: HP:0001761
      label: Pes cavus
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0001761 | Pes cavus | Frequent (79-30%) |"
    explanation: Orphanet lists pes cavus as frequent.
- category: Musculoskeletal
  name: Talipes Equinovarus
  description: Talipes equinovarus is a frequent foot posture abnormality.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Talipes equinovarus
    term:
      id: HP:0001762
      label: Talipes equinovarus
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0001762 | Talipes equinovarus | Frequent (79-30%) |"
    explanation: Orphanet lists talipes equinovarus as frequent.
- category: Musculoskeletal
  name: Torticollis
  description: Torticollis is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Torticollis
    term:
      id: HP:0000473
      label: Torticollis
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0000473 | Torticollis | Frequent (79-30%) |"
    explanation: Orphanet lists torticollis as frequent.
- category: Neuropsychiatric
  name: Depression
  description: Depression is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Depression
    term:
      id: HP:0000716
      label: Depression
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0000716 | Depression | Frequent (79-30%) |"
    explanation: Orphanet lists depression as frequent.
- category: Neuropsychiatric
  name: Anxiety
  description: Anxiety is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0000739 | Anxiety | Frequent (79-30%) |"
    explanation: Orphanet lists anxiety as frequent.
- category: Neurologic
  name: Sleep Abnormality
  description: Sleep abnormality is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0002360 | Sleep abnormality | Frequent (79-30%) |"
    explanation: Orphanet lists sleep abnormality as frequent.
- category: Constitutional
  name: Fatigue
  description: Fatigue is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0012378 | Fatigue | Frequent (79-30%) |"
    explanation: Orphanet lists fatigue as frequent.
- category: Audiologic
  name: Hearing Impairment
  description: Hearing impairment is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| HP:0000365 | Hearing impairment | Frequent (79-30%) |"
    explanation: Orphanet lists hearing impairment as frequent.
- category: Metabolic
  name: Transient Hyperphenylalaninemia
  description: Transient hyperphenylalaninemia is listed as frequent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Transient hyperphenylalaninemia
    term:
      id: HP:0008297
      label: Transient hyperphenylalaninemia
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |
    explanation: Orphanet lists transient hyperphenylalaninemia as frequent.
biochemical:
- name: CSF homovanillic acid
  presence: DECREASED
  context: >-
    Low CSF homovanillic acid is a central dopamine-metabolite clue that reports
    impaired dopamine biosynthesis in GTPCH1-deficient dopa-responsive dystonia.
  biomarker_term:
    preferred_term: CSF homovanillic acid
    term:
      id: CHEBI:545959
      label: homovanillic acid
  readouts:
  - target: Striatal Dopamine Biosynthesis Impairment
    relationship: READOUT_OF
    direction: NEGATIVE
    endpoint_context: DIAGNOSTIC
    interpretation: Low CSF HVA reports reduced central dopamine synthesis.
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0003785 | Decreased CSF homovanillic acid concentration | Frequent
      (79-30%) |
    explanation: Orphanet lists decreased CSF homovanillic acid as frequent.
- name: Blood phenylalanine
  presence: INCREASED
  context: >-
    Transient hyperphenylalaninemia is a metabolic readout of the BH4-dependent
    aromatic amino-acid hydroxylation branch in this Orphanet disease record.
  biomarker_term:
    preferred_term: L-phenylalanine
    term:
      id: CHEBI:58095
      label: L-phenylalanine zwitterion
  readouts:
  - target: BH4-Dependent Catecholamine and Phenylalanine Hydroxylation Impairment
    relationship: READOUT_OF
    direction: POSITIVE
    endpoint_context: DIAGNOSTIC
    interpretation: Elevated blood phenylalanine reports impaired BH4-dependent phenylalanine handling.
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | HP:0008297 | Transient hyperphenylalaninemia | Frequent (79-30%) |
    explanation: Orphanet lists transient hyperphenylalaninemia as frequent.
genetic:
- name: GCH1 heterozygous pathogenic variants
  gene_term:
    preferred_term: GCH1
    term:
      id: hgnc:4193
      label: GCH1
  association: Autosomal dominant pathogenic variants
  variant_origin: GERMLINE
  features: >-
    Heterozygous pathogenic variants in GCH1 cause the classic
    GTPCH1-deficient autosomal dominant dopa-responsive dystonia phenotype.
  inheritance:
  - name: Autosomal dominant
    description: >-
      The disorder is inherited in an autosomal dominant manner with reduced
      penetrance, particularly in males.
    evidence:
    - reference: PMID:20301681
      reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        GTPCH1-deficient DRD is inherited in an autosomal dominant manner.
        Affected individuals often have an affected parent with typical
        GTPCH1-deficient DRD or adult-onset parkinsonism caused by a GCH1
        pathogenic variant.
      explanation: GeneReviews supports autosomal dominant inheritance.
  evidence:
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of GTPCH1-deficient DRD is established in a proband by
      identification of a heterozygous pathogenic variant in GCH1 by molecular
      genetic testing.
    explanation: Supports GCH1 heterozygous pathogenic variants as diagnostic.
- name: IMPDH2 loss-of-function variants
  gene_term:
    preferred_term: IMPDH2
    term:
      id: hgnc:6053
      label: IMPDH2
  association: Loss-of-function variants
  variant_origin: GERMLINE
  features: >-
    Rare IMPDH2 loss-of-function variants are reported in dominantly inherited
    juvenile-onset dystonia-tremor and are listed by Orphanet for this disease.
  evidence:
  - reference: DOI:10.1038/s41431-021-00939-1
    reference_title: 'IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here we report a deleterious heterozygous truncating variant in the
      inosine monophosphate dehydrogenase gene (IMPDH2) by whole-exome
      sequencing, co-segregating with a dominantly inherited dystonia-tremor
      disease in a large Finnish family.
    explanation: Supports IMPDH2 as a rarer autosomal dominant dystonia gene.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | IMPDH2 | inosine monophosphate dehydrogenase 2 | hgnc:6053 |
      Disease-causing germline mutation(s) (loss of function) in |
    explanation: Orphanet lists IMPDH2 for this disease entry.
- name: NR4A2 loss-of-function variants
  gene_term:
    preferred_term: NR4A2
    term:
      id: hgnc:7981
      label: NR4A2
  association: Loss-of-function variants
  variant_origin: GERMLINE
  features: >-
    NR4A2 loss-of-function variants can cause dystonia-parkinsonism with
    dopaminergic denervation and are listed by Orphanet for this disease.
  evidence:
  - reference: PMID:31922365
    reference_title: Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Two frameshift mutations in NR4A2 were identified: a de novo insertion
      (NM_006186.3; c.326dupA) in the first case and another small insertion
      (NM_006186.3; c.881dupA) in the second.
    explanation: Supports NR4A2 loss-of-function variants in human cases.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      | NR4A2 | nuclear receptor subfamily 4 group A member 2 | hgnc:7981 |
      Disease-causing germline mutation(s) (loss of function) in |
    explanation: Orphanet lists NR4A2 for this disease entry.
diagnosis:
- name: Molecular genetic testing
  presence: Positive
  description: >-
    Diagnosis is established by identifying a heterozygous pathogenic variant in
    GCH1; broader panels may also assess rarer autosomal dominant genes such as
    IMPDH2 and NR4A2 when the phenotype is atypical.
  evidence:
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of GTPCH1-deficient DRD is established in a proband by
      identification of a heterozygous pathogenic variant in GCH1 by molecular
      genetic testing.
    explanation: GeneReviews supports molecular genetic testing for diagnosis.
- name: Levodopa responsiveness
  presence: Positive
  description: >-
    Dramatic and sustained response to low-dose levodopa is a defining clinical
    diagnostic clue.
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A rare neurometabolic disorder characterized by childhood-onset dystonia
      that shows a dramatic and sustained response to low doses of levodopa
      (L-dopa) and that may be associated with parkinsonism at an older age.
    explanation: Orphanet definition supports levodopa responsiveness.
  - reference: PMID:33875303
    reference_title: 'Early-onset autosomal dominant GTP-cyclohydrolase I deficiency: Diagnostic delay and residual motor signs.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Early clinical suspicion, timely diagnosis, and levodopa treatment may
      reduce the occurrence of RMS in patients with early-onset AD GCH1
      deficiency.
    explanation: >-
      Human case-series/meta-analysis supports early recognition and levodopa
      treatment.
- name: Biochemical testing
  presence: Positive
  description: >-
    Biochemical testing of pterin or neurotransmitter-related markers may be
    needed when the clinical phenotype suggests GTPCH1-deficient
    dopa-responsive dystonia but molecular testing does not identify a GCH1
    pathogenic variant.
  evidence:
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In individuals with a suspected diagnosis of GTPCH1-deficient DRD and no
      identifiable GCH1 pathogenic variants, biochemical testing may be
      necessary.
    explanation: >-
      GeneReviews supports biochemical testing as a diagnostic fallback when
      suspected GTPCH1-deficient DRD lacks an identifiable GCH1 variant.
treatments:
- name: Low-dose levodopa therapy
  description: >-
    Low-dose levodopa, typically with a decarboxylase inhibitor, bypasses the
    upstream dopamine-synthesis bottleneck and produces rapid, sustained motor
    improvement. Discontinuation of levodopa treatment should be avoided.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: levodopa
      term:
        id: CHEBI:15765
        label: L-dopa
  target_phenotypes:
  - preferred_term: Limb dystonia
    term:
      id: HP:0002451
      label: Limb dystonia
  - preferred_term: Parkinsonism
    term:
      id: HP:0001300
      label: Parkinsonism
  target_mechanisms:
  - target: Striatal Dopamine Biosynthesis Impairment
    treatment_effect: BYPASSES
  evidence:
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Motor benefit occurs immediately or within a few days of starting
      levodopa; full benefit occurs within several days to a few months.
      Maximum benefit (complete or near-complete responsiveness of symptoms) is
      generally achieved by <300-400 mg/day of levodopa/DCI.
    explanation: >-
      GeneReviews supports low-dose levodopa as the core symptomatic therapy.
  - reference: PMID:20301681
    reference_title: GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Agents/circumstances to avoid: Discontinuation of levodopa treatment."
    explanation: GeneReviews states that discontinuing levodopa should be avoided.
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A rare neurometabolic disorder characterized by childhood-onset dystonia
      that shows a dramatic and sustained response to low doses of levodopa
      (L-dopa) and that may be associated with parkinsonism at an older age.
    explanation: Orphanet definition supports dramatic sustained levodopa response.
prevalence:
- population: Europe
  percentage: 1-9 / 1 000 000
  notes: Orphanet records European point prevalence in the one-to-nine per million range.
  evidence:
  - reference: ORPHA:98808
    reference_title: Autosomal dominant dopa-responsive dystonia
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "| 1-9 / 1 000 000 | Europe | Point prevalence | ORPHANET |"
    explanation: Orphanet lists European point prevalence.
📚

References & Deep Research

References

8
ORPHA:98808
Autosomal dominant dopa-responsive dystonia
1 finding
Orphanet defines autosomal dominant dopa-responsive dystonia as a rare neurometabolic disorder with childhood-onset dystonia and sustained low-dose levodopa response.
"A rare neurometabolic disorder characterized by childhood-onset dystonia that shows a dramatic and sustained response to low doses of levodopa (L-dopa) and that may be associated with parkinsonism at an older age."
Show evidence (1 reference)
ORPHA:98808 SUPPORT Other
"A rare neurometabolic disorder characterized by childhood-onset dystonia that shows a dramatic and sustained response to low doses of levodopa (L-dopa) and that may be associated with parkinsonism at an older age."
Orphanet definition supports the disease scope and core clinical response pattern.
PMID:20301681
GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
1 finding
GeneReviews supports GCH1 molecular diagnosis, autosomal dominant inheritance, core clinical characteristics, and levodopa management.
"GTPCH1-deficient DRD is characterized by childhood-onset dystonia, diurnal fluctuation, dramatic sustained response to low-dose levodopa, and diagnosis by heterozygous GCH1 pathogenic variant."
PMID:8852666
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.
1 finding
Human family evidence identifies GCH1/GTPCH as a causative gene for dopa-responsive dystonia.
"The study analyzed British families and sporadic cases after GTPCH was identified as the first causative gene for dopa-responsive dystonia."
PMID:28087438
Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.
1 finding
DRD genes affect dopamine and tetrahydrobiopterin biosynthesis.
"The cohort review states that DRD is caused by mutations in genes encoding enzymes involved in dopamine and tetrahydrobiopterin biosynthesis."
PMID:33875303
Early-onset autosomal dominant GTP-cyclohydrolase I deficiency: Diagnostic delay and residual motor signs.
1 finding
Early-onset AD GCH1 deficiency commonly has gait disturbance and diurnal fluctuation, and delayed diagnosis is associated with residual motor signs.
"Case-series and meta-analysis data reported gait disturbance in 92.7%, diurnal fluctuation in 91.9%, and an association between diagnostic delay and residual motor signs."
PMID:31922365
Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.
1 finding
NR4A2 loss-of-function variants can cause dystonia parkinsonism with dopaminergic denervation.
"Two patients had NR4A2 frameshift variants, dystonia parkinsonism, and DATscan evidence suggesting bilateral dopaminergic denervation."
DOI:10.1038/s41431-021-00939-1
IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder
1 finding
IMPDH2 truncating variants cause a dominantly inherited dystonia-tremor disorder with patient-cell IMPDH2 deficiency.
"The study reports a heterozygous truncating IMPDH2 variant cosegregating with dominantly inherited dystonia-tremor disease and degradation of the gene product in patient cells."
DOI:10.1002/mdc3.14157
Autosomal Recessive Guanosine Triphosphate Cyclohydrolase I Deficiency: Redefining the Phenotypic Spectrum and Outcomes
1 finding
GCH1 encodes GTP cyclohydrolase I, the rate-limiting enzyme in tetrahydrobiopterin biosynthesis and a cofactor source for monoamine neurotransmitter production.
"The GCH1 gene encodes the enzyme guanosine triphosphate cyclohydrolase I (GTPCH), which catalyzes the rate‐limiting step in the biosynthesis of tetrahydrobiopterin (BH4), a critical cofactor in the production of monoamine neurotransmitters."

Deep Research

1
Autosomal Dominant Dopa-Responsive Dystonia Deep Research Fallback ▸

Autosomal Dominant Dopa-Responsive Dystonia Deep Research Fallback

Provider Attempts

  • falcon: just research-disorder falcon Autosomal_Dominant_Dopa_Responsive_Dystonia started and remained silent for more than one minute; terminated with signal 15.
  • openai: just research-disorder openai Autosomal_Dominant_Dopa_Responsive_Dystonia started and remained silent for more than one minute; terminated with signal 15.

Because the providers did not return a usable report, curation proceeded from generated Orphanet ORPHA:98808 and a bounded set of fetched PubMed/DOI references.

Integrated Literature Synthesis

Autosomal dominant dopa-responsive dystonia is a rare neurometabolic disorder with childhood-onset dystonia, frequent parkinsonism and extrapyramidal motor features, and a characteristic dramatic response to low-dose levodopa. Orphanet lists the disease as MONDO:0971063 / ORPHA:98808 and provides the definition, European point prevalence, disease genes, and frequent HPO phenotypes.

The canonical mechanism is GCH1 deficiency. Human family studies identify GCH1, encoding GTP cyclohydrolase I, as the first causative gene for dopa-responsive dystonia. GeneReviews states that diagnosis is established by a heterozygous pathogenic variant in GCH1 and that the disorder is autosomal dominant with reduced penetrance. Mechanistically, GCH1 affects tetrahydrobiopterin biosynthesis; human cohort evidence links DRD to genes encoding enzymes involved in dopamine and tetrahydrobiopterin biosynthesis. This supports a graph from GCH1 enzymatic deficiency to impaired striatal dopamine biosynthesis and downstream dystonia/parkinsonism.

Rarer genes were represented because they are listed directly in ORPHA:98808. IMPDH2 evidence comes from a dominantly inherited Finnish dystonia-tremor family with a heterozygous truncating variant and patient-cell evidence of IMPDH2 deficiency. NR4A2 evidence comes from two patients with loss-of-function variants, dystonia parkinsonism, and DATscan evidence of bilateral dopaminergic denervation.

Treatment evidence centers on levodopa. GeneReviews describes immediate to near-term motor benefit and complete or near-complete responsiveness at low daily doses of levodopa/decarboxylase inhibitor, with chronic levodopa motor complications typically absent. Orphanet defines the disorder by dramatic and sustained low-dose levodopa response.

Key References

  • ORPHA:98808 - Orphanet structured record for definition, phenotype frequencies, gene rows, cross-references, and prevalence.
  • PMID:20301681 - GeneReviews for GCH1 diagnosis, clinical characteristics, inheritance, and levodopa management.
  • PMID:8852666 - Human family evidence identifying GCH1/GTPCH as a causative gene for dopa-responsive dystonia.
  • PMID:28087438 - Human DRD cohort linking dopamine and tetrahydrobiopterin biosynthesis genes to disease mechanism.
  • PMID:33875303 - Early-onset AD GCH1 deficiency case series/meta-analysis with gait disturbance, diurnal fluctuation, diagnostic delay, residual signs, and levodopa treatment relevance.
  • PMID:31922365 - NR4A2 loss-of-function dystonia-parkinsonism cases with dopaminergic denervation.
  • DOI:10.1038/s41431-021-00939-1 - IMPDH2 truncating variant, patient-cell deficiency, and guanine metabolism/dopamine synthesis link.